Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

March 01, 1994; Volume 45,Issue 3
  • You have access
    Cloning and expression of a new member of the L-2-amino-4-phosphonobutyric acid-sensitive class of metabotropic glutamate receptors.
    J A Saugstad, J M Kinzie, E R Mulvihill, T P Segerson and G L Westbrook
    Molecular Pharmacology March 1994, 45 (3) 367-372;
  • You have access
    Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.
    L K Simmons, P C May, K J Tomaselli, R E Rydel, K S Fuson, E F Brigham, S Wright, I Lieberburg, G W Becker and D N Brems
    Molecular Pharmacology March 1994, 45 (3) 373-379;
  • You have access
    Sensitization of adenylate cyclase by halothane in human myocardium and S49 lymphoma wild-type and cyc- cells: evidence for inactivation of the inhibitory G protein Gi alpha.
    M Böhm, U Schmidt, P Gierschik, R H Schwinger, S Böhm and E Erdmann
    Molecular Pharmacology March 1994, 45 (3) 380-389;
  • You have access
    Negative antagonists promote an inactive conformation of the beta 2-adrenergic receptor.
    P Samama, G Pei, T Costa, S Cotecchia and R J Lefkowitz
    Molecular Pharmacology March 1994, 45 (3) 390-394;
  • You have access
    Systemic dexamethasone administration increases septal Trk autophosphorylation in adult rats via an induction of nerve growth factor.
    M S Saporito, E R Brown, K C Hartpence, H M Wilcox, E Robbins, J L Vaught and S Carswell
    Molecular Pharmacology March 1994, 45 (3) 395-401;
  • You have access
    Pituitary cell line GH3 expresses two somatostatin receptor subtypes that inhibit adenylyl cyclase: functional expression of rat somatostatin receptor subtypes 1 and 2 in human embryonic kidney 293 cells.
    P D Garcia and R M Myers
    Molecular Pharmacology March 1994, 45 (3) 402-409;
  • You have access
    Rat somatostatin receptor type 1 couples to G proteins and inhibition of cyclic AMP accumulation.
    J R Hadcock, J Strnad and C M Eppler
    Molecular Pharmacology March 1994, 45 (3) 410-416;
  • You have access
    Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28.
    R Panetta, M T Greenwood, A Warszynska, L L Demchyshyn, R Day, H B Niznik, C B Srikant and Y C Patel
    Molecular Pharmacology March 1994, 45 (3) 417-427;
  • You have access
    The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa 1c1c7 cells by immunofluorescence microscopy.
    R S Pollenz, C A Sattler and A Poland
    Molecular Pharmacology March 1994, 45 (3) 428-438;
  • You have access
    Localization of a pioglitazone response element in the adipocyte fatty acid-binding protein gene.
    P K Harris and R F Kletzien
    Molecular Pharmacology March 1994, 45 (3) 439-445;
  • You have access
    Antimalarial action of hydrophilic drugs: involvement of aqueous access routes to intracellular parasites.
    M Loyevsky and Z I Cabantchik
    Molecular Pharmacology March 1994, 45 (3) 446-452;
  • You have access
    Human metallothionein isoform gene expression in cisplatin-sensitive and resistant cells.
    Y Y Yang, E S Woo, C E Reese, R R Bahnson, N Saijo and J S Lazo
    Molecular Pharmacology March 1994, 45 (3) 453-460;
  • You have access
    Human histamine N-methyltransferase pharmacogenetics: cloning and expression of kidney cDNA.
    B Girard, D M Otterness, T C Wood, R Honchel, E D Wieben and R M Weinshilboum
    Molecular Pharmacology March 1994, 45 (3) 461-468;
  • You have access
    Coordinate induction of glutathione S-transferase alpha, mu, and pi expression in murine liver after a single administration of oltipraz.
    M L Clapper, L C Everley, L A Strobel, A J Townsend and P F Engstrom
    Molecular Pharmacology March 1994, 45 (3) 469-474;
  • You have access
    Formation of heteromeric gamma-aminobutyric acid type A receptors containing two different alpha subunits.
    T A Verdoorn
    Molecular Pharmacology March 1994, 45 (3) 475-480;
  • You have access
    Differential expression of the beta-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation.
    B S Whaley, N Yuan, L Birnbaumer, R B Clark and R Barber
    Molecular Pharmacology March 1994, 45 (3) 481-489;
  • You have access
    Inverse agonist activity of beta-adrenergic antagonists.
    P Chidiac, T E Hebert, M Valiquette, M Dennis and M Bouvier
    Molecular Pharmacology March 1994, 45 (3) 490-499;
  • You have access
    Evidence for a common molecular mode of action for chemically distinct nonpeptide antagonists at the neurokinin-1 (substance P) receptor.
    U Gether, X Emonds-Alt, J C Brelière, T Fujii, D Hagiwara, L Pradier, C Garret, T E Johansen and T W Schwartz
    Molecular Pharmacology March 1994, 45 (3) 500-508;
  • You have access
    Estradiol reduction of the agonist high affinity form of the alpha 2-adrenoceptor in the hypothalamus of female rats: identification as the alpha 2D subtype.
    G B Karkanias and A M Etgen
    Molecular Pharmacology March 1994, 45 (3) 509-516;
  • You have access
    An arginine residue conserved in most G protein-coupled receptors is essential for the function of the m1 muscarinic receptor.
    S Z Zhu, S Z Wang, J Hu and E E el-Fakahany
    Molecular Pharmacology March 1994, 45 (3) 517-523;
  • You have access
    Determinants of alpha 2-adrenergic receptor activation of G proteins: evidence for a precoupled receptor/G protein state.
    W N Tian, E Duzic, S M Lanier and R C Deth
    Molecular Pharmacology March 1994, 45 (3) 524-531;
  • You have access
    Two distinct ATP signaling mechanisms in differentiated neuroblastoma x glioma hybrid NG108-15 cells.
    S H Chueh, L S Hsu and S L Song
    Molecular Pharmacology March 1994, 45 (3) 532-539;
  • You have access
    N-methyl-D-aspartate receptors: different subunit requirements for binding of glutamate antagonists, glycine antagonists, and channel-blocking agents.
    D R Lynch, N J Anegawa, T Verdoorn and D B Pritchett
    Molecular Pharmacology March 1994, 45 (3) 540-545;
  • You have access
    Human alpha 7 acetylcholine receptor: cloning of the alpha 7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in Xenopus oocytes.
    X Peng, M Katz, V Gerzanich, R Anand and J Lindstrom
    Molecular Pharmacology March 1994, 45 (3) 546-554;
  • You have access
    Role of tyrosine 337 in the binding of huperzine A to the active site of human acetylcholinesterase.
    Y Ashani, J Grunwald, C Kronman, B Velan and A Shafferman
    Molecular Pharmacology March 1994, 45 (3) 555-560;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 45, Issue 3
1 Mar 1994
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics